For over a decade and a half, the medical community has grappled with a paradox in cardiovascular health management.

Statins, while undeniably effective in lowering cholesterol, do little to reduce heart disease risk and cause significant side effects, including an increased risk of Type 2 diabetes.

A groundbreaking study has now provided the most comprehensive evidence to date on this connection, confirming and expanding upon findings first hinted at in earlier research.